← FDA Drug Approvals (Drugs@FDA)
FLUVOXAMINE MALEATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APPCO · Approved 2026-04-30
Drug application
- FDA Application #
ANDA220328- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FLUVOXAMINE MALEATE
- Generic name
- Fluvoxamine Maleate
- Active ingredients
- FLUVOXAMINE MALEATE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- APPCO
- First approval
- 2026-04-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown